Chronic Traumatic Encephalopathy: A Comparison with Alzheimer's Disease and Frontotemporal Dementia

Abstract

The clinical diagnosis of chronic traumatic encephalopathy (CTE) is challenging due to heterogeneous clinical presentations and overlap with other neurodegenerative dementias. Depending on the clinical presentation, the differential diagnosis of CTE includes Alzheimer's disease (AD), behavioral variant frontotemporal dementia (bvFTD), Parkinson's disease, amyotrophic lateral sclerosis, primary mood disorders, posttraumatic stress disorder, and psychotic disorders. The aim of this article is to compare the clinical aspects, genetics, fluid biomarkers, imaging, treatment, and pathology of CTE to those of AD and bvFTD. A detailed clinical evaluation, neurocognitive assessment, and structural brain imaging can inform the differential diagnosis, while molecular biomarkers can help exclude underlying AD pathology. Prospective studies that include clinicopathological correlations are needed to establish tools that can more accurately determine the cause of neuropsychiatric decline in patients at risk for CTE.

Keywords

chronic traumatic encephalopathy - differential diagnosis - Alzheimer's disease - frontotemporal dementia

Publikationsverlauf

Artikel online veröffentlicht:
20. August 2020

• References

• 1 Mez J, Daneshvar DH, Kiernan PT. , et al. Clinicopathological evaluation of chronic traumatic encephalopathy in players of American football. JAMA 2017; 318 (04) 360-370
• 2 McKee AC, Stern RA, Nowinski CJ. , et al. The spectrum of disease in chronic traumatic encephalopathy. Brain 2013; 136 (Pt 1): 43-64
• 3 Martland HS. Punch drunk. JAMA 1928; 91 (15) 1103-1107
• 4 Baugh CM, Robbins CA, Stern RA, McKee AC. Current understanding of chronic traumatic encephalopathy. Curr Treat Options Neurol 2014; 16 (09) 306
• 5 Goldstein LE, Fisher AM, Tagge CA. , et al. Chronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse model. Sci Transl Med 2012; 4 (134) 134ra60
• 6 McKee AC, Cantu RC, Nowinski CJ. , et al. Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol 2009; 68 (07) 709-735
• 7 Gardner RC, Possin KL, Hess CP. , et al. Evaluating and treating neurobehavioral symptoms in professional American football players: lessons from a case series. Neurol Clin Pract 2015; 5 (04) 285-295
• 8 Stern RA, Daneshvar DH, Baugh CM. , et al. Clinical presentation of chronic traumatic encephalopathy. Neurology 2013; 81 (13) 1122-1129
• 9 Fleminger S, Oliver DL, Lovestone S, Rabe-Hesketh S, Giora A. Head injury as a risk factor for Alzheimer's disease: the evidence 10 years on; a partial replication. J Neurol Neurosurg Psychiatry 2003; 74 (07) 857-862
• 10 Deutsch MB, Mendez MF, Teng E. Interactions between traumatic brain injury and frontotemporal degeneration. Dement Geriatr Cogn Disord 2015; 39 (3-4): 143-153
• 11 Rabinovici GD. Late-onset Alzheimer disease. Continuum (Minneap Minn) 2019; 25 (01) 14-33
• 12 Erkkinen MG, Kim MO, Geschwind MD. Clinical neurology and epidemiology of the major neurodegenerative diseases. Cold Spring Harb Perspect Biol 2018; 10 (04) a033118
• 13 Seeley WW. Behavioral variant frontotemporal dementia. Continuum (Minneap Minn) 2019; 25 (01) 76-100
• 14 Bang J, Spina S, Miller BL. Frontotemporal dementia. Lancet 2015; 386 (10004): 1672-1682
• 15 The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994; 57 (04) 416-418
• 16 Finger EC. Frontotemporal dementias. Continuum (Minneap Minn) 2016; 22 (2, Dementia): 464-489
• 17 Mayeux R, Stern Y. Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med 2012; 2 (08) a006239
• 18 Reitz C, Mayeux R. Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem Pharmacol 2014; 88 (04) 640-651
• 19 Hebert LE, Beckett LA, Scherr PA, Evans DA. Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Dis Assoc Disord 2001; 15 (04) 169-173
• 20 Hebert LE, Weuve J, Scherr PA, Evans DA. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology 2013; 80 (19) 1778-1783
• 21 Podcasy JL, Epperson CN. Considering sex and gender in Alzheimer disease and other dementias. Dialogues Clin Neurosci 2016; 18 (04) 437-446
• 22 Ratnavalli E, Brayne C, Dawson K, Hodges JR. The prevalence of frontotemporal dementia. Neurology 2002; 58 (11) 1615-1621
• 23 Johnson JK, Diehl J, Mendez MF. , et al. Frontotemporal lobar degeneration: demographic characteristics of 353 patients. Arch Neurol 2005; 62 (06) 925-930
• 24 Onyike CU, Diehl-Schmid J. The epidemiology of frontotemporal dementia. Int Rev Psychiatry 2013; 25 (02) 130-137
• 25 Knopman DS, Petersen RC, Edland SD, Cha RH, Rocca WA. The incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994. Neurology 2004; 62 (03) 506-508
• 26 Li Y, Li Y, Li X. , et al. Head injury as a risk factor for dementia and Alzheimer's disease: a systematic review and meta-analysis of 32 observational studies. PLoS One 2017; 12 (01) e0169650
• 27 Abner EL, Nelson PT, Schmitt FA. , et al. Self-reported head injury and risk of late-life impairment and AD pathology in an AD center cohort. Dement Geriatr Cogn Disord 2014; 37 (5-6): 294-306
• 28 Crane PK, Gibbons LE, Dams-O'Connor K. , et al. Association of traumatic brain injury with late-life neurodegenerative conditions and neuropathologic findings. JAMA Neurol 2016; 73 (09) 1062-1069
• 29 Kalkonde YV, Jawaid A, Qureshi SU. , et al. Medical and environmental risk factors associated with frontotemporal dementia: a case-control study in a veteran population. Alzheimers Dement 2012; 8 (03) 204-210
• 30 Rosso SM, Landweer E-J, Houterman M, DonkerKaat L, van Duijn CM, van Swieten JC. Medical and environmental risk factors for sporadic frontotemporal dementia: a retrospective case-control study. J Neurol Neurosurg Psychiatry 2003; 74 (11) 1574-1576
• 31 LoBue C, Wilmoth K, Cullum CM. , et al. Traumatic brain injury history is associated with earlier age of onset of frontotemporal dementia. J Neurol Neurosurg Psychiatry 2016; 87 (08) 817-820
• 32 Montenigro PH, Baugh CM, Daneshvar DH. , et al. Clinical subtypes of chronic traumatic encephalopathy: literature review and proposed research diagnostic criteria for traumatic encephalopathy syndrome. Alzheimers Res Ther 2014; 6 (05) 68
• 33 Rice TB, Dunn RE, Lincoln AE. , et al; National Football League Subcommittee on Cardiovascular Health. Sleep-disordered breathing in the National Football League. Sleep 2010; 33 (06) 819-824
• 34 George CFP, Kab V, Kab P, Villa JJ, Levy AM. Sleep and breathing in professional football players. Sleep Med 2003; 4 (04) 317-325
• 35 Rogers AJ, Xia K, Soe K. , et al. Obstructive sleep apnea among players in the National Football League: a scoping review. J Sleep Disord Ther 2017; 6 (05) 278
• 36 Albuquerque FN, Kuniyoshi FHS, Calvin AD. , et al. Sleep-disordered breathing, hypertension, and obesity in retired National Football League players. J Am Coll Cardiol 2010; 56 (17) 1432-1433
• 37 McKee AC, Daneshvar DH, Alvarez VE, Stein TD. The neuropathology of sport. Acta Neuropathol 2014; 127 (01) 29-51
• 38 Madsen T, Erlangsen A, Orlovska S, Mofaddy R, Nordentoft M, Benros ME. Association between traumatic brain injury and risk of suicide. JAMA 2018; 320 (06) 580-588
• 39 Goldstein L, Diaz-Arrastia R. Traumatic brain injury and risk of suicide. JAMA 2018; 320 (06) 554-556
• 40 Maroon JC, Winkelman R, Bost J, Amos A, Mathyssek C, Miele V. Chronic traumatic encephalopathy in contact sports: a systematic review of all reported pathological cases. PLoS One 2015; 10 (02) e0117338
• 41 Corsellis JA, Bruton CJ, Freeman-Browne D. The aftermath of boxing. Psychol Med 1973; 3 (03) 270-303
• 42 Mawdsley C, Ferguson FR. Neurological disease in boxers. Lancet 1963; 2 (7312): 795-801
• 43 McKhann GM, Knopman DS, Chertkow H. , et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7 (03) 263-269
• 44 Dubois B, Feldman HH, Jacova C. , et al. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. Lancet Neurol 2014; 13 (06) 614-629
• 45 Markowitsch HJ, Staniloiu A. Amnesic disorders. Lancet 2012; 380 (9851): 1429-1440
• 46 Mendez MF, Lee AS, Joshi A, Shapira JS. Nonamnestic presentations of early-onset Alzheimer's disease. Am J Alzheimers Dis Other Demen 2012; 27 (06) 413-420
• 47 Sha SJ, Rabinovici GD. Atypical Alzheimer's disease. In: Geschwind MD, Belkoura CR. , eds. Non-Alzheimer's and Atypical Dementia. John Wiley & Sons, Ltd; 2016: 17-29
• 48 Geda YE, Schneider LS, Gitlin LN. , et al; Neuropsychiatric Syndromes Professional Interest Area of ISTAART. Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future. Alzheimers Dement 2013; 9 (05) 602-608
• 49 Schneider B, Maurer K, Frölich L. Dementia and suicide. Fortschr Neurol Psychiatr 2001; 69 (04) 164-169
• 50 Rascovsky K, Hodges JR, Knopman D. , et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011; 134 (Pt 9): 2456-2477
• 51 Rabinovici GD, Miller BL. Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management. CNS Drugs 2010; 24 (05) 375-398
• 52 Pedersen HA, Ferraro FR, Himle M, Schultz C, Poolman M. Neuropsychological factors related to college ice hockey concussions. Am J Alzheimers Dis Other Demen 2014; 29 (03) 201-204
• 53 Belanger HG, Vanderploeg RD. The neuropsychological impact of sports-related concussion: a meta-analysis. J Int Neuropsychol Soc 2005; 11 (04) 345-357
• 54 Belanger HG, Spiegel E, Vanderploeg RD. Neuropsychological performance following a history of multiple self-reported concussions: a meta-analysis. J Int Neuropsychol Soc 2010; 16 (02) 262-267
• 55 Mendez MF. The neuropsychiatric aspects of boxing. Int J Psychiatry Med 1995; 25 (03) 249-262
• 56 McLatchie G, Brooks N, Galbraith S. , et al. Clinical neurological examination, neuropsychology, electroencephalography and computed tomographic head scanning in active amateur boxers. J Neurol Neurosurg Psychiatry 1987; 50 (01) 96-99
• 57 Salmon DP, Bondi MW. Neuropsychological assessment of dementia. Annu Rev Psychol 2009; 60: 257-282
• 58 Bondi MW, Edmonds EC, Salmon DP. Alzheimer's disease: past, present, and future. J Int Neuropsychol Soc 2017; 23 (9-10): 818-831
• 59 Jicha GA, Nelson PT. Hippocampal sclerosis, argyrophilic grain disease, and primary age-related tauopathy. Continuum (Minneap Minn) 2019; 25 (01) 208-233
• 60 Perry DC, Brown JA, Possin KL. , et al. Clinicopathological correlations in behavioural variant frontotemporal dementia. Brain 2017; 140 (12) 3329-3345
• 61 Ranasinghe KG, Rankin KP, Lobach IV. , et al. Cognition and neuropsychiatry in behavioral variant frontotemporal dementia by disease stage. Neurology 2016; 86 (07) 600-610
• 62 Jordan BD. The clinical spectrum of sport-related traumatic brain injury. Nat Rev Neurol 2013; 9 (04) 222-230
• 63 Victoroff J. Traumatic encephalopathy: review and provisional research diagnostic criteria. Neuro Rehabilitation 2013; 32 (02) 211-224
• 64 Reams N, Eckner JT, Almeida AA. , et al. A clinical approach to the diagnosis of traumatic encephalopathy syndrome: a review. JAMA Neurol 2016; 73 (06) 743-749
• 65 Mez J, Solomon TM, Daneshvar DH. , et al. Assessing clinicopathological correlation in chronic traumatic encephalopathy: rationale and methods for the UNITE study. Alzheimers Res Ther 2015; 7 (01) 62
• 66 The DIAGNOSE-CTE Research Project - Full Text View - ClinicalTrials.gov. Available at: https://clinicaltrials.gov/ct2/show/NCT02798185 . Accessed January 22, 2019
• 67 Ossenkoppele R, Pijnenburg YAL, Perry DC. , et al. The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features. Brain 2015; 138 (Pt 9): 2732-2749
• 68 Falcon B, Zivanov J, Zhang W. , et al. Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules. Nature 2019; 568 (7752): 420-423
• 69 Stein TD, Montenigro PH, Alvarez VE. , et al. Beta-amyloid deposition in chronic traumatic encephalopathy. Acta Neuropathol 2015; 130 (01) 21-34
• 70 McKee AC, Gavett BE, Stern RA. , et al. TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol 2010; 69 (09) 918-929
• 71 Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 1986; 83 (13) 4913-4917
• 72 Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A 1985; 82 (12) 4245-4249
• 73 Goedert M, Spillantini MG. A century of Alzheimer's disease. Science 2006; 314 (5800): 777-781
• 74 Duyckaerts C, Delatour B, Potier M-C. Classification and basic pathology of Alzheimer disease. Acta Neuropathol 2009; 118 (01) 5-36
• 75 Mirra SS, Heyman A, McKeel D. , et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41 (04) 479-486
• 76 Dugger BN, Dickson DW. Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol 2017; 9 (07) a028035
• 77 Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991; 82 (04) 239-259
• 78 Braak H, Thal DR, Ghebremedhin E, Del Tredici K. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 2011; 70 (11) 960-969
• 79 Perry DC, Miller BL. Frontotemporal dementia. Semin Neurol 2013; 33 (04) 336-341
• 80 Ljubenkov PA, Miller BL. A clinical guide to frontotemporal dementias. Focus Am Psychiatr Publ 2016; 14 (04) 448-464
• 81 Mckee AC, Abdolmohammadi B, Stein TD. The neuropathology of chronic traumatic encephalopathy. In: Hainline B, Stern RA. , eds. Handbook of Clinical Neurology. Vol 158. Sports Neurology. Elsevier; 2018: 297-307
• 82 DeKosky ST, Abrahamson EE, Ciallella JR. , et al. Association of increased cortical soluble abeta42 levels with diffuse plaques after severe brain injury in humans. Arch Neurol 2007; 64 (04) 541-544
• 83 Jordan BD, Relkin NR, Ravdin LD, Jacobs AR, Bennett A, Gandy S. Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing. JAMA 1997; 278 (02) 136-140
• 84 Kutner KC, Erlanger DM, Tsai J, Jordan B, Relkin NR. Lower cognitive performance of older football players possessing apolipoprotein E epsilon4. Neurosurgery 2000; 47 (03) 651-657 , discussion 657–658
• 85 Terrell TR, Bostick RM, Abramson R. , et al. APOE, APOE promoter, and tau genotypes and risk for concussion in college athletes. Clin J Sport Med 2008; 18 (01) 10-17
• 86 Terrell TR, Abramson R, Barth JT. , et al. Genetic polymorphisms associated with the risk of concussion in 1056 college athletes: a multicentre prospective cohort study. Br J Sports Med 2018; 52 (03) 192-198
• 87 Bieniek KF, Ross OA, Cormier KA. , et al. Chronic traumatic encephalopathy pathology in a neurodegenerative disorders brain bank. Acta Neuropathol 2015; 130 (06) 877-889
• 88 Campion D, Dumanchin C, Hannequin D. , et al. Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet 1999; 65 (03) 664-670
• 89 Liu C-C, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 2013; 9 (02) 106-118
• 90 Neu SC, Pa J, Kukull W. , et al. Apolipoprotein E genotype and sex risk factors for Alzheimer disease: a meta-analysis. JAMA Neurol 2017; 74 (10) 1178-1189
• 91 Carmona S, Hardy J, Guerreiro R. The genetic landscape of Alzheimer disease. Handb Clin Neurol 2018; 148: 395-408
• 92 Ridge PG, Hoyt KB, Boehme K. , et al; Alzheimer's Disease Genetics Consortium (ADGC). Assessment of the genetic variance of late-onset Alzheimer's disease. Neurobiol Aging 2016; 41: 200.e13-200.e20
• 93 Karch CM, Cruchaga C, Goate AM. Alzheimer's disease genetics: from the bench to the clinic. Neuron 2014; 83 (01) 11-26
• 94 Sieben A, Van Langenhove T, Engelborghs S. , et al. The genetics and neuropathology of frontotemporal lobar degeneration. Acta Neuropathol 2012; 124 (03) 353-372
• 95 Galimberti D, Scarpini E. Behavioral genetics of neurodegenerative disorders. Curr Top Behav Neurosci 2012; 12: 615-631
• 96 Pittman AM, Myers AJ, Abou-Sleiman P. , et al. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. J Med Genet 2005; 42 (11) 837-846
• 97 Suzuki H, Matsuoka M. The lysosomal trafficking transmembrane protein 106B is linked to cell death. J Biol Chem 2016; 291 (41) 21448-21460
• 98 Rubin LH, Tierney R, Kawata K. , et al. NFL blood levels are moderated by subconcussive impacts in a cohort of college football players. Brain Inj 2019; 33 (04) 456-462
• 99 Alosco ML, Tripodis Y, Jarnagin J. , et al. Repetitive head impact exposure and later-life plasma total tau in former National Football League players. Alzheimers Dement (Amst) 2016; 7: 33-40
• 100 Stern RA, Tripodis Y, Baugh CM. , et al. Preliminary study of plasma exosomal tau as a potential biomarker for chronic traumatic encephalopathy. J Alzheimers Dis 2016; 51 (04) 1099-1109
• 101 Zetterberg H, Blennow K. Chronic traumatic encephalopathy: fluid biomarkers. Handb Clin Neurol 2018; 158: 323-333
• 102 Niemantsverdriet E, Ottoy J, Somers C. , et al. The cerebrospinal fluid Aβ1-42/Aβ1-40 ratio improves concordance with amyloid-PET for diagnosing Alzheimer's disease in a clinical setting. J Alzheimers Dis 2017; 60 (02) 561-576
• 103 Janelidze S, Zetterberg H, Mattsson N. , et al; Swedish BioFINDER Study Group. CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease. Ann Clin Transl Neurol 2016; 3 (03) 154-165
• 104 Mattsson N, Lönneborg A, Boccardi M, Blennow K, Hansson O. Geneva Task Force for the Roadmap of Alzheimer's Biomarkers. Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework. Neurobiol Aging 2017; 52: 196-213
• 105 Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 2006; 5 (03) 228-234
• 106 Ovod V, Ramsey KN, Mawuenyega KG. , et al. Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis. Alzheimers Dement 2017; 13 (08) 841-849
• 107 Nakamura A, Kaneko N, Villemagne VL. , et al. High performance plasma amyloid-β biomarkers for Alzheimer's disease. Nature 2018; 554 (7691): 249-254
• 108 Mielke MM, Hagen CE, Xu J. , et al. Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography. Alzheimers Dement 2018; 14 (08) 989-997
• 109 Mielke MM, Hagen CE, Wennberg AMV. , et al. Association of plasma total tau level with cognitive decline and risk of mild cognitive impairment or dementia in the Mayo Clinic study on aging. JAMA Neurol 2017; 74 (09) 1073-1080
• 110 Mattsson N, Andreasson U, Zetterberg H, Blennow K. Alzheimer's Disease Neuroimaging Initiative. Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease. JAMA Neurol 2017; 74 (05) 557-566
• 111 Borroni B, Benussi A, Premi E. , et al. Biological, neuroimaging, and neurophysiological markers in frontotemporal dementia: three faces of the same coin. J Alzheimers Dis 2018; 62 (03) 1113-1123
• 112 Borroni B, Gardoni F, Parnetti L. , et al. Pattern of tau forms in CSF is altered in progressive supranuclear palsy. Neurobiol Aging 2009; 30 (01) 34-40
• 113 Borroni B, Benussi A, Archetti S. , et al. CSF p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia. Amyotroph Lateral Scler Frontotemporal Degener 2015; 16 (1-2): 86-91
• 114 Steinacker P, Anderl-Straub S, Diehl-Schmid J. , et al; FTLDc Study Group. Serum neurofilament light chain in behavioral variant frontotemporal dementia. Neurology 2018; 91 (15) e1390-e1401
• 115 Gardner RC, Hess CP, Brus-Ramer M. , et al. Cavum septum pellucidum in retired American pro-football players. J Neurotrauma 2016; 33 (01) 157-161
• 116 Lee JK, Wu J, Banks S. , et al. Prevalence of traumatic findings on routine MRI in a large cohort of professional fighters. AJNR Am J Neuroradiol 2017; 38 (07) 1303-1310
• 117 Koerte IK, Hufschmidt J, Muehlmann M. , et al. Cavum septi pellucidi in symptomatic former professional football players. J Neurotrauma 2016; 33 (04) 346-353
• 118 Coughlin JM, Wang Y, Munro CA. , et al. Neuroinflammation and brain atrophy in former NFL players: an in vivo multimodal imaging pilot study. Neurobiol Dis 2015; 74: 58-65
• 119 Lepage C, Muehlmann M, Tripodis Y. , et al. Limbic system structure volumes and associated neurocognitive functioning in former NFL players. Brain Imaging Behav 2019; 13 (03) 725-734
• 120 Schultz V, Stern RA, Tripodis Y. , et al. Age at first exposure to repetitive head impacts is associated with smaller thalamic volumes in former professional American football players. J Neurotrauma 2018; 35 (02) 278-285
• 121 Bernick C, Banks SJ, Shin W. , et al. Repeated head trauma is associated with smaller thalamic volumes and slower processing speed: the Professional Fighters' Brain Health Study. Br J Sports Med 2015; 49 (15) 1007-1011
• 122 Peskind ER, Petrie EC, Cross DJ. , et al. Cerebrocerebellar hypometabolism associated with repetitive blast exposure mild traumatic brain injury in 12 Iraq war Veterans with persistent post-concussive symptoms. Neuroimage 2011; 54 (Suppl. 01) S76-S82
• 123 Provenzano FA, Jordan B, Tikofsky RS, Saxena C, Van Heertum RL, Ichise M. F-18 FDG PET imaging of chronic traumatic brain injury in boxers: a statistical parametric analysis. Nucl Med Commun 2010; 31 (11) 952-957
• 124 Bang SA, Song YS, Moon BS. , et al. Neuropsychological, metabolic, and GABAA receptor studies in subjects with repetitive traumatic brain injury. J Neurotrauma 2016; 33 (11) 1005-1014
• 125 Mitsis EM, Riggio S, Kostakoglu L. , et al. Tauopathy PET and amyloid PET in the diagnosis of chronic traumatic encephalopathies: studies of a retired NFL player and of a man with FTD and a severe head injury. Transl Psychiatry 2014; 4: e441
• 126 Dickstein DL, Pullman MY, Fernandez C. , et al. Cerebral [¹⁸F]T807/AV1451 retention pattern in clinically probable CTE resembles pathognomonic distribution of CTE tauopathy. Transl Psychiatry 2016; 6 (09) e900
• 127 Stern RA, Adler CH, Chen K. , et al. Tau positron-emission tomography in former National Football League Players. New Eng J Med 2019; 380 (18) 1716-1725
• 128 Baker SL, Harrison TM, Maass A, La Joie R, Jagust WJ. Effect of off-target binding on 18F-flortaucipir variability in healthy controls across the life span. J Nucl Med 2019; 60 (10) 1444-1451
• 129 Barrio JR. The irony of PET tau probe specificity. J Nucl Med 2018; 59 (01) 115-116
• 130 Small GW, Kepe V, Siddarth P. , et al. PET scanning of brain tau in retired national football league players: preliminary findings. Am J Geriatr Psychiatry 2013; 21 (02) 138-144
• 131 Barrio JR, Small GW, Wong K-P. , et al. In vivo characterization of chronic traumatic encephalopathy using [F-18]FDDNP PET brain imaging. Proc Natl Acad Sci U S A 2015; 112 (16) E2039-E2047
• 132 Ossenkoppele R, Tolboom N, Foster-Dingley JC. , et al. Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET. Eur J Nucl Med Mol Imaging 2012; 39 (06) 990-1000
• 133 Desikan RS, Rafii MS, Brewer JB, Hess CP. An expanded role for neuroimaging in the evaluation of memory impairment. AJNR Am J Neuroradiol 2013; 34 (11) 2075-2082
• 134 Frisoni GB, Bocchetta M, Chételat G. , et al; ISTAART's NeuroImaging Professional Interest Area. Imaging markers for Alzheimer disease: which vs how. Neurology 2013; 81 (05) 487-500
• 135 Aziz A-L, Giusiano B, Joubert S. , et al. Difference in imaging biomarkers of neurodegeneration between early and late-onset amnestic Alzheimer's disease. Neurobiol Aging 2017; 54: 22-30
• 136 Frisoni GB, Pievani M, Testa C. , et al. The topography of grey matter involvement in early and late onset Alzheimer's disease. Brain 2007; 130 (Pt 3): 720-730
• 137 Shivamurthy VKN, Tahari AK, Marcus C, Subramaniam RM. Brain FDG PET and the diagnosis of dementia. AJR Am J Roentgenol 2015; 204 (01) W76-W85
• 138 Ossenkoppele R, Jansen WJ, Rabinovici GD. , et al; Amyloid PET Study Group. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. JAMA 2015; 313 (19) 1939-1949
• 139 Ossenkoppele R, Schonhaut DR, Schöll M. , et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. Brain 2016; 139 (Pt 5): 1551-1567
• 140 Bejanin A, Schonhaut DR, La Joie R. , et al. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease. Brain 2017; 140 (12) 3286-3300
• 141 Rosen HJ, Gorno-Tempini ML, Goldman WP. , et al. Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology 2002; 58 (02) 198-208
• 142 Schroeter ML, Raczka K, Neumann J, Yves von Cramon D. Towards a nosology for frontotemporal lobar degenerations-a meta-analysis involving 267 subjects. Neuroimage 2007; 36 (03) 497-510
• 143 Seeley WW, Crawford R, Rascovsky K. , et al. Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia. Arch Neurol 2008; 65 (02) 249-255
• 144 Jeong Y, Cho SS, Park JM. , et al. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients. J Nucl Med 2005; 46 (02) 233-239
• 145 Utianski RL, Whitwell JL, Schwarz CG. , et al. Tau-PET imaging with [18F]AV-1451 in primary progressive apraxia of speech. Cortex 2018; 99: 358-374
• 146 Smith R, Schöll M, Widner H. , et al. In vivo retention of ¹⁸F-AV-1451 in corticobasal syndrome. Neurology 2017; 89 (08) 845-853
• 147 Schonhaut DR, McMillan CT, Spina S. , et al. ¹⁸F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: a multicenter study. Ann Neurol 2017; 82 (04) 622-634
• 148 Makaretz SJ, Quimby M, Collins J. , et al. Flortaucipir tau PET imaging in semantic variant primary progressive aphasia. J Neurol Neurosurg Psychiatry 2018; 89 (10) 1024-1031
• 149 Petersen RC, Lopez O, Armstrong MJ. , et al. Practice guideline update summary: Mild cognitive impairment: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 2018; 90 (03) 126-135
• 150 Aisen PS, Cummings J, Schneider LS. Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease. Cold Spring Harb Perspect Med 2012; 2 (03) a006395
• 151 Boxer AL, Knopman DS, Kaufer DI. , et al. Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 2013; 12 (02) 149-156
• 152 Mendez MF, Shapira JS, McMurtray A, Licht E. Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia. Am J Geriatr Psychiatry 2007; 15 (01) 84-87